HAG
CRL icon

HighPoint Advisor Group’s Charles River Laboratories CRL Stock Holding History

HighPoint Advisor Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-907
Closed -$222K – 708
2024
Q2 		$222K Sell
907
-47
-5% -$10.7K 0.01% 556
2024
Q1 		$218K Sell
954
-18
-2% -$4.3K 0.02% 579
2023
Q4 		$258K Buy
+972
New +$191K 0.02% 514
2022
Q2 		$320K Buy
+1,416
New +$346K 0.04% 386
2021
Q3 		$955K Buy
2,314
+87
+4% +$36.1K 0.09% 177
2021
Q2 		$824K Buy
2,227
+67
+3% +$22.4K 0.08% 203
2021
Q1 		$662K Sell
2,160
-156
-7% -$43.4K 0.08% 214
2020
Q4 		$644K Buy
2,316
+1,015
+78% +$242K 0.08% 204
2020
Q3 		$327K Sell
1,301
-409
-24% -$84.9K 0.06% 256
2020
Q2 		$300K Sell
1,710
-254
-13% -$40.5K 0.06% 244
2020
Q1 		$268K Buy
+1,964
New +$295K 0.06% 232
2019
Q4 		– Sell
-887
Closed -$115K – 392
2019
Q3 		$115K Buy
887
+104
+13% +$13.9K 0.03% 438
2019
Q2 		$106K Buy
+783
New +$106K 0.02% 443
2017
Q4 		– Sell
-8,056
Closed -$944K – 302
2017
Q3 		$944K Buy
8,056
+2,643
+49% +$272K 0.29% 87
2017
Q2 		$539K Hold
5,413
– – 0.17% 148
2017
Q1 		$539K Buy
+5,413
New +$460K 0.17% 148

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

HighPoint Advisor Group's CRL Position: Q3 2024 in Review

HighPoint Advisor Group sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 907 shares — an estimated $222K sold.

HighPoint Advisor Group first reported a position in CRL in Q1 2017 and held it in 16 quarters. The position peaked at $955K in Q3 2021. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • HighPoint Advisor Group reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • HighPoint Advisor Group sold 907 Charles River Laboratories shares in Q3 2024, an estimated $222K.
  • HighPoint Advisor Group first reported a position in Charles River Laboratories in Q1 2017 and held it in 16 quarters.
  • HighPoint Advisor Group's Charles River Laboratories position peaked at $955K in Q3 2021.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on HighPoint Advisor Group's 13F filing for Q3 2024, filed 4 Nov 2024.